JENNIFER PARKHURST: Open Payments
NPI 1669871943 · OREGON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,341 in 76 payments from 14 companies in 2025. Trend: 2023 $843 · 2024 $1,474 · 2025 $1,341
Food & beverage: $1,341
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $319 |
| Novo Nordisk Inc | 16 | $237 |
| AstraZeneca Pharmaceuticals LP | 7 | $152 |
| Axsome Therapeutics, Inc. | 8 | $143 |
| Lilly USA, LLC | 9 | $109 |
| PFIZER INC. | 3 | $109 |
| Exact Sciences Corporation | 5 | $101 |
| GlaxoSmithKline, LLC. | 3 | $53 |
| Dexcom, Inc. | 1 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
Products named: Auvelity, Ozempic, VRAYLAR, BREZTRI, UBRELVY, Cologuard Collection Kit, MOUNJARO, Wegovy.
Industry payments across OH — which companies pay providers there.
